SILVERTHORNE, CO
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)KEYSTONE SYMPOSIA ON MOLECULAR AND CELLULAR BIOLOGY, founded in 1972, is a mid-sized nonprofit in the Science & Technology sector that reported $11.4M in total revenue in fiscal year 2024. Revenue decreased 6% compared to the prior year. Expenses of $12.9M exceeded revenue, resulting in a 13% operating deficit.
KEYSTONE SYMPOSIA WILL SERVE AS A CATALYST FOR THE ADVANCEMENT OF BIOMEDICAL LIFE SCIENCES BY CONNECTING SCIENTISTS WITHIN AND ACROSS DISCIPLINES AT CONFERENCES AND WORKSHOPS HELD AT VENUES THAT CREATE AN ENVIRONMENT CONDUCIVE TO INFORMATION EXCHANGE.
KEYSTONE SYMPOSIA SPONSORS AN ANNUAL SERIES OF CONFERENCES FOR THE SCIENTIFIC COMMUNITY, WHICH ARE INTERNATIONAL IN SCOPE AND FOCUS ON NEW AND EMERGING AREAS OF MOLECULAR AND CELLULAR BIOLOGY AS THEY...
KEYSTONE SYMPOSIA SPONSORS AN ANNUAL SERIES OF CONFERENCES FOR THE SCIENTIFIC COMMUNITY, WHICH ARE INTERNATIONAL IN SCOPE AND FOCUS ON NEW AND EMERGING AREAS OF MOLECULAR AND CELLULAR BIOLOGY AS THEY APPLY TO BASIC BIOLOGY, HUMAN MEDICINE, AND AGRICULTURE. IN FY2025, THE KEYSTONE SYMPOSIA CONVENED 52 IN-PERSON CONFERENCES ACROSS THE GLOBE. FOR EACH MEETING, WE ADDITIONALLY OFFERED RECORDED ON-DEMAND CONTENT OF THE TALKS. IN ADDITION, KEYSTONE SYMPOSIA PROVIDED 314 SCHOLARSHIPS TO EARLY CAREER SCIENTISTS TO ATTEND MEETINGS AND PRESENT THEIR WORK. SEVERAL OF THE MEETINGS ALSO INCORPORATED A CAREER ROUNDTABLE. THESE WORKSHOPS PROVIDED CAREER ADVICE AND INSIGHT FROM DIVERSE(CONT'D ON SCH. O)CAREER PATHS FOR TRAINEES ASPIRING TO FOLLOW IN THEIR FOOTSTEPS. KEYSTONE SYMPOSIA PROVIDED 14 POSTDOCS AND EARLY-CAREER SCIENTISTS FROM DISADVANTAGE BACKGROUNDS AN OPPORTUNITY TO PARTICIPATE IN THE FELLOWS PROGRAM. THE PROGRAM AIMS TO ENHANCE CONFIDENCE, LEADERSHIP SKILLS, NETWORKING OPPORTUNITIES AND VISIBILITY OF FELLOWS WITHIN THE BIOLOGICAL AND BIOMEDICAL RESEARCH COMMUNITY.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $11,371,337 | $12,101,803 | -0.1% |
| Expenses | $12,895,876 | $12,109,586 | +0.1% |
| Net Income | $-1,524,539 | $-7,783 | +194.9% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| JAMIE M BAUMGARTNER | PRESIDENT & CEO (FROM 7/24) | 40.00 |
Officer
Director
|
$154,153 | $16,912 | $171,065 |
| WALTER H MOOS PHD | CHAIR OF BOARD | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| MARGARET A GOODELL PHD | SECRETARY | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| IAN M COLRAIN PHD | TREASURER | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| CHERIE L BUTTS PHD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MORRIS J BIRNBAUM MD PHD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| NANCY J BROWN MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| RICHARD D DIMARCHI PHD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MARIA C FREIRE PHD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MATTIAS FYRENIUS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| VERONIQUE KIERMER PHD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| TONY HUNTER PHD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| KIERSTEN STEAD PHD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| LORI SUSSEL PHD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JOSEPH C WU MD PHD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JULEEN R ZIERATH PHD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| DEBORAH L JOHNSON PHD | PRESIDENT & CEO(THRU 9/24) | 40.00 |
Officer
Director
|
$359,088 | $21,600 | $380,688 |
| MIKE PAGE | DIRECTOR(FROM 1/25) | 1.00 |
Director
|
$0 | $0 | $0 |
| TERRY L SHEPPARD PHD | EX-OFFICIO DIR/CHIEF SCIENCE OFFICER | 40.00 |
Officer
|
$251,587 | $23,563 | $275,150 |
| PAMELA DAUGHERTY | CHIEF FINANCIAL OFFICER | 40.00 |
Officer
|
$187,551 | $38,554 | $226,105 |
| MINDA MASON | SENIOR DIRECTOR OF DEVELOPMENT | 40.00 |
Highest
|
$150,269 | $19,115 | $169,384 |
| JOSH MAY | DIRECTOR, TECHNOLOGY & COMM. | 40.00 |
Highest
|
$115,536 | $17,060 | $132,596 |
| CHRIS HENRY | DIRECTOR OF OPERATIONS | 40.00 |
Highest
|
$124,930 | $7,473 | $132,403 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $11,371,337 | $12,895,876 | $21,867,265 | $-1,524,539 |
| 2024 | $12,101,803 | $12,109,586 | $21,614,158 | $-7,783 |
| 2023 | $14,937,075 | $13,247,202 | $20,245,044 | $1,689,873 |
| 2022 | $9,290,392 | $10,116,483 | $18,786,234 | $-826,091 |
| 2021 | $7,402,542 | $7,330,012 | $19,886,137 | $72,530 |
| 2020 | $8,920,247 | $10,191,632 | $18,727,690 | $-1,271,385 |
| 2019 | $17,506,416 | $15,696,676 | $20,932,001 | $1,809,740 |
| 2018 | $14,838,421 | $14,522,372 | $18,728,860 | $316,049 |
Compare KEYSTONE SYMPOSIA ON MOLECULAR AND CELLULAR BIOLOGY with other nonprofits in Colorado and across the country.